David First - 24 Jan 2023 Form 4 Insider Report for SQZ Biotechnologies Co

Role
Chief People Officer
Signature
/s/Lawrence Knopf as attorney in fact for David First
Issuer symbol
N/A
Transactions as of
24 Jan 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2023, 15:44:10 UTC
Previous filing
15 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +200,000 $0.000000 200,000 24 Jan 2023 Common Stock 200,000 $0.7300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.